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Molecular Characterization of Protease Activity in Serratia sp. Strain
SCBI and Its Importance in Cytotoxicity and Virulence
Lauren M. Petersen, Louis S. Tisa
Department of Molecular, Cellular, and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire, USA
A newly recognized Serratia species, termed South African Caenorhabditis briggsae isolate (SCBI), is both a mutualist of the
nematode Caenorhabditis briggsae KT0001 and a pathogen of lepidopteran insects. Serratia sp. strain SCBI displays high proteo-
lytic activity, and because secreted proteases are known virulence factors for many pathogens, the purpose of this study was to
identify genes essential for extracellular protease activity in Serratia sp. strain SCBI and to determine what role proteases play in
insect pathogenesis and cytotoxicity. A bank of 2,100 transposonmutants was generated, and six SCBI mutants with defective
proteolytic activity were identified. These mutants were also defective in cytotoxicity. The mutants were found defective in genes
encoding the following proteins: alkaline metalloprotease secretion protein AprE, a BglB family transcriptional antiterminator,
an inosine/xanthosine triphosphatase, GidA, a methyl-accepting chemotaxis protein, and a PIN domain protein. Gene expres-
sion analysis on these six mutants showed significant downregulation in mRNA levels of several different types of predicted pro-
tease genes. In addition, transcriptome sequencing (RNA-seq) analysis provided insight into how inactivation of AprE, GidA,
and a PIN domain protein influences motility and virulence, as well as protease activity. Using quantitative reverse transcrip-
tion-PCR (qRT-PCR) to further characterize expression of predicted protease genes in wild-type Serratia sp. SCBI, the highest
mRNA levels for the alkaline metalloprotease genes (termed prtA1 to prtA4) occurred following the death of an insect host, while
two serine protease and twometalloprotease genes had their highest mRNA levels during active infection. Overall, these results
indicate that proteolytic activity is essential for cytotoxicity in Serratia sp. SCBI and that its regulation appears to be highly
complex.
Members of the genus Serratia are found widespread aroundthe globe and are well-known for their roles as insect patho-
gens (1, 2). A newly recognized Serratia species, termed South
African Caenorhabditis briggsae isolate (SCBI), was identified fol-
lowing its isolation from the nematode C. briggsae KT0001 (3).
These C. briggsae KT0001 nematodes were recovered from soil
samples through Galleria mellonella bait traps in three provinces
in South Africa (3). While Serratia sp. strain SCBI is nonpatho-
genic to Caenorhabditis nematodes, these bacteria are lethal to G.
mellonella and the tobacco hornworm, Manduca sexta (4). When
injected into the hemocoel of either species in numbers less than
1,000 CFU, larvae die within 72 h.
A hallmark of Serratia spp. is their ability to produce and se-
crete a variety of enzymes into the external milieu. Expression and
secretion of these exoenzymes, which includes proteases, lipases,
DNases, and chitinases, are usually growth phase dependent, with
activities not seen until late-exponential or stationary-phase
growth (5–8). In addition, expression of these exoenzymes is
largely regulated by the substrate uponwhich they degrade (9–11).
The plethora of extracellular proteins produced by Serratia spp.
allow for invasion and colonization of a wide number of habitats,
thereby contributing directly or indirectly to virulence against a
broad host range. In particular, protease activity has been recog-
nized as a virulence factor in the opportunistic pathogen Serratia
marcescens, with proteases actively contributing to both insect and
human pathogenesis (12, 13).
S. marcescens is capable of secreting multiple kinds of pro-
teases, yet the majority of activity is due to a 56-kDa metallopro-
tease termed PrtA, or serralysin (14, 15). Secreted by a typical ABC
transport system termed LipBCD (16, 17), PrtA causes a variety of
pathogenic effects. When cultured, keratitis-causing Serratia spp.
produce up to 10more proteases and cause more-severe lesions
than isolates that exhibit less proteolytic activity. The severity of
these infections is directly correlated with PrtA levels (18). On a
molecular level, PrtA enhances vascular permeability through ac-
tivation of the Hageman factor/kallikrein-kinin system (19–21).
PrtA degrades various protease inhibitors and crucial components
of the mammalian host complement system in human plasma,
reducing the ability of the host to clear pathogens (15, 22–24).
PrtA also destroys immunoglobulin (IgG and IgA) by hydrolyzing
the heavy chains of these immunoglobulins near the hinge region
(15, 25). In human lung squamous cell carcinoma EBC-1 cells,
PrtA induces an inflammatory response through the activation of
a protease-activated receptor 2, inducing interleukin-6 and inter-
leukin-8 expression (26).
Protease activity in Serratia has also been linked with invasion
and destruction of various mammalian cell lines. Incubation of
fibroblast cells with purified S. marcescens PrtA results in the de-
struction ofmore than 50%of cells within 1 h (15).Mutant strains
lacking the 56-kDa metalloprotease are no longer cytotoxic to-
ward HeLa cells (27). Proteases found in Serratia proteamaculans
and Serratia grimesii also have cytotoxic properties. S. pro-
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teamaculans strain 94 produces a 32-kDa thermostable protealy-
sin that is able of cleaving filamentous actin and matrix metallo-
proteaseMMP2 in human larynx carcinomaHEp-2 cells (28–30).
Additionally, S. proteamaculans strain 94 is able to infect HEp-2
cells andwas retained within approximately 10% of cells. This was
the first finding that any S. proteamaculans strain was capable of
eukaryotic cell invasion. Similarly, S. grimesii produces grimely-
sin, a novel metalloprotease, which has specific actin-hydrolyzing
activity and mediates HEp-2 cell invasion (31).
While the genes responsible for protease activity and secretion
have been elucidated in S. marcescens, the mechanisms regulating
the expression of PrtA and other proteases are not well under-
stood. There is very little knowledge of the transcription factors
involved in the regulation of protease production. However, lipB
(the ATP-binding component of the LipBCD transporter) expres-
sion is under the control of the swr quorum-sensing system in S.
marcescens (32). In addition, the catabolite regulation protein
(CRP) of S. marcescens is an indirect regulator of PrtA, and its
inactivation results in increased proteolytic activity (33). CRP acts
as a global regulator, and its activity is influenced by the intracel-
lular cyclic AMP (cAMP) concentration, which in turn is regu-
lated by the level of intracellular glucose. Besides affecting pro-
tease activity, the role of cAMP-CRP has been linked to chitinase
and phospholipase activities, as well as pilus and flagellum pro-
duction (33, 34).
Similar to other Serratia spp., Serratia sp. strain SCBI has pro-
tease, lipase, DNase, alkaline phosphatase, and chitinase activities,
and is cytotoxic toward the mammalian Buffalo green monkey
kidney (BGMK) cell line (4). The Serratia sp. strain SCBI genome
contains a high number of protease genes, including four PrtA
homologues, at least two extracellular serine proteases, and two or
more extracellular metalloproteases (F. Abebe-Akele, L. S. Tisa,
V. S. Cooper, P. J. Hatcher, E. Abebe, andW. K. Thomas, submit-
ted for publication). The goal of this study was to determine
whether or not protease activity was important in insect patho-
genesis and cytotoxicity in Serratia sp. SCBI. The first step was to
identify mutants defective in proteolytic activity by screening a
miniHimar RB1 transposon mutant library on skim milk agar
plates. Six mutants were identified, the point of transposon inser-
tion was determined, and these mutants were assayed for cytotox-
icity, virulence, motility, and hemolysis. For several of these mu-
tants with significantly altered virulence, their transcriptomes
were analyzed by transcriptome sequencing (RNA-seq). To gain
further insight into whether protease activity may play a role in
insect pathogenesis and cytotoxicity, quantitative reverse tran-
scription-PCR (qRT-PCR)was utilized to ascertain the conditions
under which expression of eight predicted protease genes was op-
timal in Serratia sp. SCBI.
MATERIALS AND METHODS
Bacterial strains and growth conditions. A complete list of all bacterial
strains and plasmids used in this study is given in Table 1. Bacteria were
grown overnight at 37°C in LBmedium (1% tryptone, 0.5% yeast extract,
1% NaCl) with appropriate antibiotics when required.
Cell culture growth conditions. Buffalo green monkey kidney
(BGMK) cells were grown and maintained at 37°C in minimum essential
medium (Flow Laboratories) supplemented with medium 199 (Sigma),
10% fetal bovine serum (FBS), 16mMHEPES buffer, 12 mMNaHCO3, 2
mM L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin,
pH 7.3.
Constructionof Serratia sp. strain SCBI transposonmutant library.
Serratia sp. strain SCBI was mutagenized by the use of the MiniHimar
transposon RB1 (35). Both the donor (Escherichia coli S17-1 pir/pMini-
Himar RB1) and recipient (Serratia sp. SCBI) were grown overnight in LB
medium containing appropriate antibiotics (30 g/ml kanamycin for the
donor and 10 g/ml polymyxin B sulfate for the recipient). One milliliter
of each culture was centrifuged at 10,000 g for 2 min, and the pellet was
washed twice with phosphate-buffered saline (PBS) before 20 l of a 1:1
cell mixture was spotted onto the center of an LB agar plate and incubated
at 37°C for 24 h. Following incubation, the cell mixture was resuspended
TABLE 1 Bacterial strains and plasmids used in this study
Bacterial strain or




SCBI Wild type 3
16-D2 Transposon mutant with disrupted aprE This study
22-A7 Transposon mutant with disrupted bglB This study
22-B9 Transposon mutant with disrupted inosine/xanthosine triphosphatase This study
22-C7 Transposon mutant with disrupted gidA This study
22-D7 Transposon mutant with disrupted MCP This study
22-F6 Transposon mutant with disrupted PIN protein This study
E. coli strains
S17-1 pir Tpr Smr recA thi pro hsdS(rm) RP4::2-Tc::Mu::Km Tn7 pir; donor strain for transposon mutagenesis 64




pMiniHimar RB1 Transposon mutagenesis 35
pCR2.1-TOPO TOPO cloning Invitrogen
pBAD33-Cm Expression vector 37
pBAD33-AprE pBAD33 vector containing cloned aprE plus tolC This study
pBAD33-GidA pBAD33 vector containing cloned gidA This study
pBAD33-MCP pBAD33 vector containing cloned gene (SCBI_0077) coding for MCP This study
pBAD33-PIN pBAD33 vector containing cloned gene (SCBI_0044) coding for the PIN protein This study
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in 1 ml PBS, and transconjugants were selected by overnight growth of
100-l aliquots from 105 and 106 dilutions on LB agar containing 100
g/ml kanamycin and 30 g/ml polymyxin B sulfate at 37°C. A total of
2,100 isolated transconjugant colonies were selected and grown at 37°C
overnight in LB medium containing 40 g/ml kanamycin and 10 g/ml
polymyxin B sulfate in 96-well plates before addition of an equal volume
of 60% glycerol and storage at80°C for future use.
Molecular analysis of transposon mutants. Genomic DNA (gDNA)
from each clone was prepared by the standard chloroform-isoamyl alco-
hol extraction technique. The gDNA was digested with NsiI (New Eng-
land BioLabs), which does not cut the transposon, followed by ligation
with T4 ligase (New England BioLabs). The ligated DNA was electropo-
rated into E. coliDH5 pir cells, and transformants were selected on LB
plates containing 25 g/ml kanamycin. The transposon-carrying plas-
mids were isolated and sequenced using the transposon-specific primers
Himar1 (5=-CAT TTA ATA CTA GCG ACG CCA TCT-3=) and 615 (5=-
TCG GGT ATC GCT CTT GAA GGG-3=). Sequences were compared to
the Serratia sp. SCBI genome using BLASTN.
Protease assay. Proteolytic activity was determined by a liquid azoca-
sein assay described previously (4). Briefly, cultures were grown overnight
at 28°C, which is the optimal temperature for protease activity in Serratia
sp. SCBI (4), diluted to an optical density at 600 nm (OD600) of 2.0, and
centrifuged for 5 min at 16,060 g. An aliquot of 500 l of the resulting
supernatant was mixed with 500 l of azocasein solution (2% azocasein,
50 mM Tris-HCl) and incubated for 1 h at 37°C with gentle agitation. An
aliquot of 500l of a 10% trichloroacetic acid solution was added to each
sample, shaken vigorously, and centrifuged for 10 min at 12,000 g. The
A450 of the resulting supernatant was determined on a spectrophotometer
to measure the amount of released substrate. The following equation was
used to calculate the units of enzymatic activity (U) for the protease assay:
U 
 Abs/g substrate/ml/h where Abs is absorbance. Activity was stan-
dardized as units per 109 cells. Cell numbers were determined by the
OD600 reading of the culture prior to centrifugation. An OD600 of 1.0
represents 2 109 cells/ml.
To test the inhibitory effect of protease inhibitors, 50 mM EDTA
and/or 1 mM phenylmethanesulfonyl fluoride (PMSF) were added to
appropriate azocasein-supernatant samples.
Screening for mutants deficient in protease activity. Individual col-
onies of transposon-induced mutants of Serratia sp. strain SCBI were
screened for protease by the use of a skimmilk plate assay. Skimmilk agar
(1% tryptone, 0.5% yeast extract, 1%NaCl, 3% powdered skimmilk) was
poured into oversized petri dishes (150 by 15 mm; Fisher Scientific, Can-
ada). Using a 96-well replicator, the transposants stored at 80°C were
transferred into new 96-well microtiter plates containing fresh LB me-
dium containing 25 g/ml kanamycin and incubated overnight at 37°C.
The freshly grown overnight culture was replica plated directly into skim
milk medium, and the plates were incubated for 48 h at 28°C. Mutants
with loss or reduction in protease activity were confirmed by the use of a
liquid azocasein assay as described above.
Insect viability assay. Serratia sp. SCBI miniHimar RB1 mutants de-
fective in protease activity were analyzed for their ability to kill third-
instar M. sexta larvae using methods described previously (4). Briefly,
overnight bacterial cultures of mutants were initially diluted to an OD600
of 1.0 in LBmedium. The bacterial culture was further diluted severalfold
to obtain an average CFU value of 2  103 for each mutant. For each
diluted sample, 10l was directly injected into the insect hemocoel by use
of a sterilized Hamilton syringe. Wild-type Serratia sp. SCBI and E. coli
EPI300 were used as controls. For all of the samples, including the con-
trols, 10 larvae were used. The larvae were held individually with food for
up to 14 days at 37°C under a 16-h light/8-h dark cycle. This temperature
(37°C) provides the optimal rate of killing by Serratia sp. SCBI without
any significant impact on larval health (4). The larvae were monitored for
insect mortality or delays in insect development during that time period.
The insect viability assay was repeated a total of three times (in total, 30
larvawere injected per bacterial culture; 10 larva each replicate).Mortality
was measured as the percentage of larvae killed by the bacteria relative to
the total number of larvae injected per sample. From these data, the LT50
values were calculated and defined as the average time required for 50%of
the population to die from infection.
Cytotoxicity assay.Cytotoxic activity of bacterial culture supernatant
was determined on BGMK cells as described previously (4). Briefly, cell
viability assayswere carried out in 96-well flat-bottomplasticmicroplates.
BGMK cells were seeded at a density of 5  103 cells per well and incu-
bated at 37°C in growth medium overnight. Bacteria were grown over-
night in BGMK growth medium at 28°C and centrifuged for 10 min at
16,060 g, and the resulting supernatant was filter sterilized. The super-
natant samples were assayed for protein concentration using the bicin-
choninic acid (BCA) assay (Promega) and diluted to 2 mg/ml total pro-
tein. Growth medium was removed from the BGMK cells and replaced
with 2 mg/ml bacterial supernatant, and BGMK cells were incubated for
24 h at 37°C. For the positive control, 2% SDS was used, while the growth
mediumwas used as a negative control. After 24 h, the liquidmediumwas
removed from all wells, and 100 l of BGMK medium containing 0.25
mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) was added to each well. The cells were incubated for 4 h at 37°C
during which time yellow MTT was reduced to purple formazan in the
mitochondria of living BGMK cells. The colored formazan product was
dissolved in 150 l dimethyl sulfoxide (DMSO) for 15 min at 37°C with
gentle shaking. Each sample was assayed in triplicate. The conversion of
MTT to formazanwas quantified as a change inA562. The percent viability
was determined by dividing the average A562 for a given sample by the
average of the negative-control samples.
Hemolysis assay.Rates of hemolytic activityweremeasured by the use
of a liquid assay described previously (4). Serratia sp. SCBI demonstrates
the same rate of hemolytic activity at 28°C and 37°C; therefore, this assay
can be performed at either temperature. Briefly, sheep red blood cells
(SRBCs) were washed three times in phosphate-buffered saline (PBS) and
suspended to a final concentration of 10% (vol/vol) in PBS. Overnight
bacterial cultures were diluted to an OD600 of 0.005 (an estimated 4.0
106 CFU) in LBmedium. For each culture condition, 100l of the diluted
bacterial culture was removed and mixed with 1 ml washed SRBCs. The
mixture was incubated at 28°C or 37°C for 4 h with gentle agitation. Every
hour, 125-l samples were removed and centrifuged at 16,060  g for 1
min to removed unlysed SRBCs. The resulting supernatant was diluted
1:10 in distilled water (dH2O), and the A405 was determined with a spec-
trophotometer to measure the amount of released hemoglobin. For a
positive control, 1 ml of SRBCs was lysed by addition of 100 l of 20%
sodium dodecyl sulfate (SDS) and incubated at the test temperature of
28°C for 15min. For negative controls, 100l of LBmediumwas added to
1 ml washed SRBCs incubated at the test temperature of 28°C, and sam-
ples were treated as described above. The following equation was used to
calculate hemolytic units (HU): HU
 [(A405 of sample –A405 of negative
control)/A405 of positive control] 100.
Motility assay. Swimming and swarming motility was assayed as de-
scribed previously (4, 36). For swimming, the plates were incubated for 8
h at 37°C, the optimal temperature for swimming motility (4), and the
swim ring diameter was measured. For swarming, the plates were incu-
bated for 18 to 42 h at the test temperature (22°C or 28°C), and the swarm
ring diameter wasmeasured. The optimal rate of swarming by Serratia sp.
SCBI is 28°C (4), and therefore, this temperaturewas used for themajority
of swarm assays. However, the test temperature of 22°C was necessary to
assay swarming motility by mutant 16-D2 due to the increased speed at
which it moved at 28°C.
Statistical analysis. Data were analyzed by one-way analysis of vari-
ance using JMP 10 software (SDS Institute, Inc.). Student’s t test provided
comparisons of means.
Genetic complementation. For genetic complementation analysis,
the wild-type genes were amplified with primers listed in the supplemen-
tal material (see Table S1 in the supplemental material), a template of 100
ng Serratia sp. SCBI gDNA, andOneTaq hot start DNA polymerase (New
Protease Activity in Serratia sp. Strain SCBI














England BioLabs). The PCR program was as follows: (i) an initial dena-
turation step of 30 s at 94°C; (ii) 30 cycles, with 1 cycle consisting of 30 s at
94°C, 30 s at 50°C, and 3min at 68°C; (iii) a final extension step of 10 min
at 68°C. PCR products were cleaned up using the QIAquick PCR purifi-
cation kit (Qiagen) according to the manufacturer’s instructions. Ap-
proximately 100 ng of cleaned-up PCR product was cloned into vector
pCR2.1-TOPO using the TOPO TA Cloning kit (Invitrogen) following
the manufacturer’s instructions. Invitrogen primers M13 Forward (20)
and M13 Reverse were used to determine the orientation of gene inser-
tion. Depending on the orientation of the insertion in pCR2.1-TOPO,
plasmid DNAwas cut either with XbaI and SacI or with XbaI andHindIII
(New England BioLabs). Digested DNA was ligated into pBAD33Cm
(37), which had been cut with the same restriction enzymes. The vector
was subsequently renamed pBAD33-AprE, pBAD33-GidA, pBAD33-
MCP, or pBAD33-PIN, depending on which gene(s) it carried. The
pBAD33-AprE construction also contained the tolC gene. These con-
structs were electroporated into E. coli DH5 pir, and selection was
made on LB plates containing 25 g/ml chloramphenicol. Plasmids were
extracted from successfully transformed E. coliDH5pir and confirmed
by restriction analysis and sequencing. Confirmed constructs were intro-
duced into both the appropriate mutant and wild-type Serratia sp. strain
SCBI and were selected on LB plates containing 150g/ml chloramphen-
icol.
RNA extraction and cDNA synthesis. To analyze gene expression
during stationary growth phase, the cultures were grown at 22, 28, or 37°C
for 18 h, diluted to an OD600 of 0.6, centrifuged at 16,060 g for 5 min,
and treated with RNAprotect. To analyze gene expression during expo-
nential growth phase, the cultures were grown at 22, 28, or 37°C until they
reached an OD600 of 0.6 (3 h), centrifuged at 16,060 g for 5 min, and
treated with RNAprotect. To analyze expression from bacterial cells dur-
ing hemolysis, the protocol for the hemolysis assay (described above) was
followed with the modification that following 3 h of incubation, a 2-ml
aliquot (SRBCs plus bacterial cells) was collected, centrifuged at 16,060
g for 5min, and treated with RNAprotect. To obtain cells during infection
of M. sexta, the insect viability assay protocol (described above) was fol-
lowed; however, after 24 h of incubation at 37°C (while larvae were still
alive) or after 48 h of incubation (soon after larvae have died), 100 l of
hemolymph was collected by cutting a proleg of the larva or removing the
head, being careful not to cut the gut. The hemolymph was mixed with
100l PBS containing 20mg/ml L-cysteine, passed through aQiashredder
homogenizer (Qiagen), and treated with RNAprotect. All samples were
frozen overnight at 80°C. RNA extraction was performed using the
RNeasy minikit (Qiagen) following the manufacturer’s instructions, fol-
lowed by treatment with DNase (New England BioLabs). Four micro-
grams of RNA was transcribed into cDNA using GoScript reverse trans-
criptase (Promega) following the manufacturer’s instructions, quantified
with a Qubit 2.0 fluorometer (Invitrogen), and diluted to 10 ng/l.
Analysis of gene expression with quantitative RT-PCR. Amplifica-
tion and detection of gene expression were performed using the Strat-
agene Mx3000P QPCR system (Agilent Technologies). The primers used
for these experiments are listed in the supplementalmaterial (see Table S1
in the supplemental material). Each primer sequence was blasted against
the Serratia sp. SCBI genome to ensure specificity to the target gene. Stan-
dard curves were generated using Serratia sp. SCBI genomic DNA and
each primer set to test primer efficiency before use. The rplU gene was
used as the normalizer for all qRT-PCR experiments. The RT-PCRs were
done using 50 ng template cDNA, SYBR green PCR master mix (Applied
Biosystems), and primer mix (0.3 M) in a 25-l reaction mixture. The
following thermal cycler parameters were used: (i) 15 min at 95°C; (ii) 40
cycles, with 1 cycle consisting of 15 s at 95°C and 30 s at 60°C; and (iii) 1
thermal disassociation cycle of 1 min at 95°C and 30 s at 55°C for 30 s and
incremental increases in temperature to 95°C for 30 s. Reactions were
performed in triplicate, and the comparative threshold cycle method was
used to quantify gene expression.
RNA-seq sample preparation.To analyze gene expression during sta-
tionary growth phase, cultures were grown at 28°C for 18 h, diluted to an
OD600 of 0.6, centrifuged at 16,060  g for 5 min, and treated with
RNAprotect. All samples were frozen overnight at 80°C. RNA extrac-
tion was performed using the RNeasy minikit (Qiagen) following the
manufacturer’s instructions, followed by treatment with DNase (New
England BioLabs). RNA quality was evaluated on a BioAnalyzer RNA
nano chip (Agilent). rRNA was removed using the MICROBExpress bac-
terial mRNA enrichment kit (Ambion) following the manufacturer’s in-
structions. RNA cleanup was done using the MEGAclear kit (Ambion)
following the manufacturer’s instructions. cDNA libraries were prepared
using the TruSeq RNA sample preparation kit (Illumina) following the
manufacturer’s instructions. The cDNA library was verified for appropri-
ate fragment size (200 to 300 bp) on a BioAnalyzer DNA chip (Agilent).
Samples were amplified onto flow cells using an Illumina cBot and se-
quenced on an Illumina HiSeq2000.
RNA-seq data analysis. Sequencing reads were processed using CLC
Genomics Workbench version 6.5.1 (CLC bio) using the default settings
for prokaryotic genomes. Reads were transformed and normalized using
square root transformation and quantile normalization, respectively.
Reads were mapped to a version of the Serratia sp. SCBI genome that had
all rRNA genes removed with the limit for removal of low-quality se-
quences set at 0.05 and a maximum mismatch of 2 nucleotides allowed.
Statistical analysis was done on proportions using false discovery rate
(FDR) correction to compare data sets.
Accession numbers. The genome sequence and its annotations are
available at NCBI under GenBank accession numbers CP003424 and
CP003425. RNA-seq information is available in the NCBI Gene Expres-
sion Omnibus database under accession number GSE60476.
RESULTS
Identificationof six transposonmutantswithdefectiveprotease
activity. A Serratia sp. SCBI miniHimar RB1 mutant library
(2,100 mutants) was generated and screened for protease activ-
ity on skim milk agar plates. The production of clearing zones on
this medium is indicative of the presence of proteases capable of
degrading casein, and Serratia sp. SCBI shows strong activity on
skim milk agar (4). Six mutants that either failed to produce a
clearing zone or had a clearing zone smaller than that of wild-type
Serratia sp. SCBI were identified. The mutants were confirmed
with an azocasein assay and shown tomaintain a loss or reduction
of proteolytic activity (Fig. 1). Mutant 16-D2 showed no protease
activity at all, whereas mutants 22-A7, 22-B9, 22-C7, 22-D7, and
22-F6 all had a significant reduction in activity (P 0.05).
FIG 1 Six Serratia sp. SCBI transposonmutants with defective protease activ-
ity were identified. Proteolytic activity was determined using an azocasein
assay, which was performed with strains grown for 18 h at 28°C. Values are
means  standard deviations (error bars) from at least two independent ex-
periments. WT, wild type.
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Molecular characterization of the attenuated mutants. Res-
cue cloning successfully identified the gene inactivated by trans-
poson insertion in all six mutants (see Fig. S1 in the supplemental
material). No mutant had a hit in a protease gene. Mutant 16-D2
was inactivated in the aprE gene (SCBI_3625), which encodes a
predicted membrane fusion protein important in alkaline pro-
tease secretion (see Fig. S1B). Homologous to the S. marcescens
lipC gene, aprE is the second gene in a three-gene operon that
appears to encode an ABC secretion system. The predicted genes in
this operon are an ATP-binding protein, aprE, and a TolC protein.
Mutant 22-A7 had an insertion in a bglB (SCBI_3572) gene, which is
predicted to encode an antiterminator (see Fig. S1C). This BglB anti-
terminator appears to be the second gene in a two-gene operon, with
both genes predicted to code for BglB proteins.Mutant 22-B9 had an
insertion 12bpdownstreamof the start codon in apredicted inosine/
xanthosine triphosphatase gene (SCBI_0601) (see Fig. S1D).Mutant
22-C7 had an insertion in gidA (SCBI_4598), which is a predicted
tRNA uridine 5-carboxymethyl-aminomethyl modification enzyme
(see Fig. S1E). Mutant 22-D7 had an insertion in SCBI_0077, which
encodes a predictedmethyl-accepting chemotaxis protein II (see Fig.
S1F). Mutant 22-F6 had an insertion at the 177-bp position in the
SCBI_0044 gene, which codes for a predicted nucleic acid-binding
protein that contains a PINdomain (see Fig. S1G). This PINdomain
protein appears to be the second gene in a two-gene operon that also
contains a predicted copG gene.
Genetic complementation of Serratia sp. SCBImutants. The
genetically complemented mutants and controls were assayed for
protease activity using both the liquid azocasein assay and skim
milk agar plates (Table 2). The introduction of the vector without
an insert did not significantly change the phenotypes of parental
wild-type Serratia sp. SCBI or any of the mutants tested. Genetic
complementation of mutants 16-D2, 22-C7, 22-D7, and 22-F6
restored wild-type levels of proteolytic activity. These results indi-
cate that these genes were responsible for these phenotypic effects.
Introduction of bglB and the inosine/xanthosine triphosphatase
genes were unable to complement the defect in mutants 22-A7
and 22-B9.
Loss of proteolytic activity results in loss of cytotoxicity to-
ward BGMK cells. Since protease activity has been identified as a
cytotoxic factor for S. marcescens (27), the six Serratia sp. SCBI
protease mutants were tested for their cytotoxic effects against
BGMK cells. Following 24 h of incubation at 37°C, an average of
45% of BGMK cells were viable when exposed to wild-type Serra-
tia sp. SCBI supernatant (Fig. 2A). In contrast, the protease mu-
tants showed minimal cytotoxic effects (P 0.05). Between 93%
and 97% of BGMK cells were still viable in wells exposed to super-
natant from mutants 16-D2, 22-A7, 22-B9, 22-C7, 22-D7, and
22-F6. BGMKcells incubated in normal growthmediumwas used
as a control and represented 100% viability.
All six proteasemutants were altered in insect virulence.The
ability of the protease mutants to kill third-instar M. sexta larva
was assessed over a 14-day period following an intrahemocoelic
injection and incubation at 37°C (Fig. 2B). Mutant 16-D2 killed
insect larva at a significantly higher rate thanwild-type Serratia sp.
SCBI did (an LT50 value of 1.48 days versus 2.96 days, respectively,
P  0.05). The other protease mutants killed at a significantly
lower rate (P  0.05) than wild-type Serratia sp. SCBI did. Mu-
tants 22-A7, 22-B9, 22-C7, 22-D7, and 22-F6 had LT50 values of
5.98, 6.59, 8.35, 5.29, and 5.22 days, respectively. Successful ge-
TABLE 2 Genetic complementation of mutants 16-D2, 22-C7, 22-D7, and 22-F6 restored wild-type phenotypes
Straina
Radius (mm) of the clearing




value (no. of days)d,e
WT Serratia sp. strain SCBI 8.1 0.2 11.42 0.57 2.96
WT SCBI pBAD33 7.7 0.3 10.86 0.43 3.08
WT SCBI pBAD33-AprE 8.3 0.2 11.59 0.98 3.08
WT SCBI pBAD33-GidA 8.2 0.1 11.98 0.47 2.87
WT SCBI pBAD33-MCP 8.1 0.2 11.31 0.67 2.96
WT SCBI pBAD33-PIN 8.3 0.2 10.90 0.47 3.21
Mutant 16-D2 0.5 0.0* 0.25 0.05* 1.48*
Mutant 16-D2 pBAD33 0.5 0.1* 0.38 0.06* 1.61*
Mutant 16-D2 pBAD33-AprE 7.1 0.4 10.12 1.76 2.75
Mutant 22-C7 1.0 0.1* 1.24 0.27* 8.35*
Mutant 22-C7 pBAD33 1.0 0.2* 1.36 0.57* 8.49*
Mutant 22-C7 pBAD33-GidA 6.9 0.4* 9.21 2.13 3.54
Mutant 22-D7 1.0 0.2* 1.52 0.04* 5.29*
Mutant 22-D7 pBAD33 1.1 0.1* 1.59 0.05* 5.05*
Mutant 22-D7 pBAD33-MCP 7.5 0.3 9.74 2.03 3.67
Mutant 22-F6 1.2 0.2* 1.69 0.02* 5.22*
Mutant 22-F6 pBAD33 1.2 0.2* 1.56 0.01* 4.90*
Mutant 22-F6 pBAD33-PIN 7.8 0.5 10.35 1.67 3.21
a Wild-type (WT) or mutant bacterial strain alone or carrying plasmid pBAD33 or derivatives of pBAD33.
b Skim milk agar plates were spot inoculated with strains that had been grown for 18 h at 28°C in LB medium. After 48 h of incubation, the radius of the clearing zones were
measured. These values were expressed in millimeters and are the averages of four measurements. The standard deviations are from at least two independent experiments.
c Proteolytic activity was determined using an azocasein assay and performed with strains grown for 18 h at 28°C in LB medium. Values are averages of three measurements
standard deviations from at least two independent experiments.
d LT50 values represent the average time (in days) for 50% of the M. sexta larval population to die.
e Values that are significantly different (P 0.05) from the value for wild-type Serratia sp. SCBI are shown with an asterisk.
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netic complementation of mutants 16-D2, 22-C7, 22-D7, and
22-F6 restored wild-type rates of killing (Table 2).
Mutants 22-B9 and 22-C7 showed decreased rates of hemo-
lytic activity. The hemolytic capabilities of the protease mutants
were determined using a quantitative sheep blood assay. Mutants
16-D2, 22-A7, 22-D7, and 22-F6 all had wild-type rates of hemo-
lytic activity, lysing between 90 and 100%of SRBCs within the 4-h
incubation period (Fig. 3). Mutants 22-B9 and 22-C7 demon-
strated reduced rates of hemolytic activity (P 0.05), lysing only
60% and 35% of SRBCs, respectively.
Mutant16-D2showedenhanced swarmingmotility, butmu-
tant 22-C7 exhibited reduced rates of swarming motility. The
swarming motility of the protease mutants was determined using
0.65% agar PP3 plates and measuring the diameter of the swarm
ring. The optimal swarming motility of wild-type Serratia sp.
SCBI is 28°C (4), and therefore, the ability of each proteasemutant
to swarm was initially determined for all six protease mutants at
this temperature. Following 42 h of incubation at 28°C, mutant
22-C7 demonstrated reduced swarming motility (P 0.05) com-
pared to wild-type Serratia sp. SCBI (Fig. 4C). Wild-type Serratia
sp. SCBI swarmed across the entire plate by 42 h (88 mm), but
mutant 22-C7 had an average swarm ring diameter of 31.7 9.6
mm. Mutants 22-A7, 22-B9, 22-D7, and 22-F6 demonstrated
wild-type swarming motility. In contrast, mutant 16-D2 had an
increased rate of swarming motility (P  0.05) and swarmed
across the entire plate in less than 18 h. Due to its high rate of
motility, the swarming assay was repeated at 22°C with all six
mutants and wild-type Serratia sp. SCBI to assess how fast mutant
16-D2 swarmed at a suboptimal temperature. Following 18 h at
22°C, wild-type Serratia sp. SCBI and mutants 22-A7, 22-B9, 22-
C7, 22-D7, and 22-F6 had not begun swarming and appeared as a
normal colony with a diameter of between 8 and 12 mm. During
that same incubation period, mutant 16-D2 had completely
swarmed across the entire plate (88 mm) (Fig. 4A).
The rate of swimming motility was determined using 0.2%
agar plates and measuring the diameter of the swim ring. Follow-
ing 8 h of incubation at 37°C, wild-type Serratia sp. SCBI had an
average swim ring diameter of 55.2  3.2 mm (Fig. 4B). Mutant
16-D2, in contrast, had an average swim ring diameter of 69.7
4.2 mm (P 0.05). Mutant 22-C7 had a lower rate of swimming
motility compared to the parental wild-type strain (P  0.05)
with an average swim ring diameter of 27.5 1.2mm (Fig. 4D).
All other protease mutants demonstrated wild-type swimming
motility.
RNA-seq transcriptomic analysis on proteasemutants. Since
mutants 16-D2, 22-C7, and 22-F6 had defects within either regu-
latory genes or the transporter gene, we were interested in their
effect on global gene expression and performed transcriptome
analysis on thesemutants. RNAwas extracted from thesemutants
and wild-type Serratia sp. SCBI during stationary-phase growth
and used for RNA-seq analysis.
A comparison of genes expressed by mutant 16-D2 to those in
the parental wild type generated a total of 244 genes that had
FIG 2 All six protease mutants were no longer cytotoxic to BGMK cells and
displayed different levels of virulence toward M. sexta. (A) BGMK cells were
exposed to bacterial supernatant (2 mg/ml total protein) for 24 h at 37°C, and
cell viability was tested using a MTT assay. Untreated cells were used as a
negative control and represented 100% viability. Values aremeans standard
deviations (error bars) from at least two independent experiments. WT, wild
type. (B) Third-instarM. sexta larvae were injected with 2 103 CFU and held
individually at 37°C for 14 days. Mortality was measured as the percentage of
the larva population killed over time.
FIG 3 Comparison of the rates of hemolysis by wild-type Serratia sp. SCBI
and mutants. Hemolytic activity was determined against SRBCs over a 4-h
incubation period at 28°C. Values are means  standard deviations (error
bars) from at least two independent experiments.
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significant changes in their levels (1.5-fold change; P  0.05) in
their expression. Of these genes, 142 were significantly upregu-
lated (see Table S3 in the supplemental material). Eight genes
involved in motility showed increased expression. A PhoPQ-acti-
vated pathogenicity-related protein was upregulated 9.82-fold. A
type VI secretion protein, type VI secretory pathway peptidase
PulO, and type IV secretion protein IcmF were upregulated 9.26-,
5.77-, and 5.62-fold, respectively. An extracellular serine protease
and serralysin (PrtA4) were upregulated 3.45- and 2.32-fold, re-
spectively. An ABC-type bacteriocin/antibiotic exporter was up-
regulated 4-fold, and a microcin H47 secretion protein was up-
regulated 3.88-fold. A colonic acid capsular biosynthesis protein
was upregulated 1.54-fold. Also of note, the PIN domain protein
inactivated in mutant 22-F6 was upregulated 1.75-fold in mutant
16-D2. A total of 31% of all upregulated genes were hypothetical
genes, andmost of these had no assigned COG category. A total of
102 genes were significantly downregulated in mutant 16-D2
compared to wild-type Serratia sp. SCBI (see Table S4 in the sup-
plementalmaterial).Overall,many of these geneswere involved in
transcriptional regulation and metabolism. In addition, at least
three genes involved in cytochrome c synthesis were downregu-
lated. A total of 12 hypothetical genes were significantly down-
regulated.
A total of 258 genes had significantly altered expression (P 
0.05) in mutant 22-C7 compared to wild-type Serratia sp. SCBI.
Of these 258 genes, 144 had increased expression (see Table S5 in
the supplemental material). Fourteen genes involved in transcrip-
tion and translation were significantly upregulated. Eight genes in
signal transduction had increased expression. Three genes in-
volved in plasmid maintenance and stabilization were signifi-
cantly upregulated. A total of 45 hypothetical genes were upregu-
lated. A total of 114 genes were significantly downregulated in
mutant 22-C7 compared to wild-type Serratia sp. SCBI (see Table
S6 in the supplemental material). A phospholipase D gene had a
10.18-fold decrease in expression. A flagellar biosynthesis protein
and FlgN family protein, also involved in flagellar production, had
a 9.41-fold and 2.93-fold decrease in expression, respectively.
Three genes involved in iron transport encoding a siderophore-
interacting protein, ABC-type Fe3 transport periplasmic protein,
and frataxin (an iron transport protein) showed a 4.64-, 3.32-, and
2.19-fold decrease in expression, respectively. Three genes in-
volved in fimbrial production were downregulated. In addition, a
collagen-binding surface adhesion gene, spaP, was downregulated
2.12-fold. The PrtA homologues were all downregulated; how-
ever, their P values were not below 0.05, and therefore not statis-
tically significant.
A total of 280 genes had significantly altered expression (P 
0.05) inmutant 22-F6 compared towild-type Serratia sp. SCBI.Of
these 280 genes, 162 had increased expression (see Table S7 in the
supplemental material). A total of 10 genes involved in motility
were upregulated. A significant number of genes in the COG
(clusters of orthologous groups of proteins) categories replica-
tion/repair/recombination, transcription, and translation were
upregulated. This included the PIN domain protein inactivated in
mutant 22-F6 and its operon partner, the CopG family transcrip-
tional regulator (see Fig. S1G in the supplemental material). The
PIN transcriptwas a truncatedmRNA that ended at the start of the
transposon insertion. Two chitinase genes were upregulated 3.11-
fold and 2.63-fold. An esterase/lipase was upregulated 2.48-fold.
Forty-three hypothetical genes were upregulated, comprising
25.9% of all genes that had increased expression, and three of the
top five most significantly upregulated genes were hypothetical
genes. A total of 118 genes had significantly decreased expression
in mutant 22-F6 (see Table S8 in the supplemental material).
Twelve genes involved in nucleotide metabolism and transport
were significantly downregulated. An intracellular protease/ami-
dase was downregulated 18.3-fold, and an ATP-dependent pro-
tease was downregulated 2.61-fold. A peptidase M60 viral enhan-
cin protein was downregulated 4-fold. At least 14 genes involved
in transcriptional or translational regulated had significantly de-
creased expression. Seven genes associated with the outer mem-
brane were downregulated, including two permeases, an outer
membrane protein, an EnvZ/OmpR regulon moderator, tolA,
ompX, and an outer membrane lipoprotein.
FIG 4 Swarmingmotility by wild-type Serratia sp. SCBI andmutants. Mutant
16-D2 displayed increased rates of motility, but mutant 22-C7 had reduced
rates of motility. (A) Photographs of wild-type (WT) Serratia sp. SCBI and
mutant 16-D2 following 18 h at 22°C on 0.65% agar PP3 swarm plates. (B)
Photographs of wild-type Serratia sp. SCBI andmutant 16-D2 following 8 h at
37°C in 0.2% agar swim plates. (C) Photographs of wild-type Serratia sp. SCBI
andmutant 22-C7 following 42 h at 28°C on 0.65% agar PP3 swarmplates. (D)
Photographs of wild-type Serratia sp. SCBI andmutant 22-C7 following 8 h at
37°C in 0.2% agar swim plates.
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Quantitative RT-PCR was performed on four genes with sig-
nificant changes in expression in the RNA-seq analysis (the hemo-
lysin-coregulated protein ImpD, the heme exporter protein
CcmC, a bleomycin resistance protein, and flagellar protein FliZ).
Expression data from the normalized RNA-seq data compared to
qRT-PCR data demonstrated the same trends, thus confirming
that data fromboth platformswere of high quality (see Table S9 in
the supplemental material).
For the threemutants, the number of common genes that were
up- or downregulated was determined (Fig. 5). There were 12
genes upregulated by all three mutants and 19 downregulated. No
obvious patterns were found among these genes. Most of the up-
regulated genes encoded hypothetical proteins and two DNA reg-
ulatory proteins (SCBI_0214 and SCBI_3467). In general, each of
the three mutants shared a similar number of up- or downregu-
lated genes. Mutants 22-C7 and 22-F6 shared the most upregu-
lated genes, including several genes encoding transcriptional reg-
ulators (SCBI_0963, SCBI_3139, 3610, SCBI_0196, SCBI_2463,
SCBI_3253, SCBI_0339, SCBI_1671, SCBI_1757, SCBI_0983, and
SCBI_3467).However, themajority of the up- and downregulated
genes were specific to the individual mutant.
EDTAhas a strong inhibitory effect on protease activity.The
results of the transposonmutant library screen failed to produce a
mutant with a disruption in a protease gene, so we performed
further analysis on wild-type Serratia sp. SCBI to determine what
types of proteases are being secreted andwhat environmental con-
ditions had the greatest influence on the expression of predicted
protease genes. First, an azocasein assay was carried out using
several protease inhibitors in order to determine whether the pro-
tease activity was based on a metalloprotease or serine protease.
PMSF is an irreversible serine protease inhibitor, while EDTA in-
hibits metalloproteases by chelating the divalent cations necessary
for their activity. To determine whether the presence of these in-
hibitors would have an inhibitory effect on Serratia sp. strain SCBI
proteolytic activity, 1 mM PMSF and 50 mM EDTA were incor-
porated into a liquid azocasein assay.Without any inhibitors, pro-
tease activity was measured at 11.21 U (data not shown). The
addition of PMSF did not significantly affect protease activity,
lowering activity slightly to 9.56 U. However, EDTA lowered pro-
teolytic activity significantly, dropping levels to 5.66 U, a 49.5%
decrease (P 0.05). A combination of PMSF and EDTA added to
Serratia sp. SCBI supernatant resulted in the lowest proteolytic
activity of only 3.65 U and represents only 32.6% of the activity
seen without any protease inhibitors (P  0.05). The differences
seen between the addition of EDTA alone and the addition of a
combination of PMSF and EDTA were not significant. These re-
sults indicate that the majority of Serratia sp. SCBI proteolytic
activity was due to a combination of metalloprotease and serine
protease activities, but the larger portion of its activity was driven
by metalloprotease.
Temperature influences the expressionof proteases.Analysis
of the Serratia sp. SCBI genome indicates that this bacterium con-
tains the genes for at least two extracellular serine proteases, a zinc
metalloprotease (yfgC), a secretedmetalloprotease, and four alka-
line metalloproteases (see Table S2 in the supplemental material).
The two serine protease genes (SCBI_4441 and SCBI 4442) are
located next to each other in the genome and were termed serine
protease 1 and serine protease 2 for the location at which they fall
in the genome. The serine protease 1 gene is 3,093 bp, and the
serine protease 2 gene is 3,024 bp. The zinc metalloprotease yfgC
(SCBI_3465) and the secreted metalloprotease gene (SCBI_3545)
are 1,470 bp and 1,026 bp, respectively. The four alkaline metal-
loproteases are homologues of the metalloprotease prtA (also
known as serralysin). These four prtA homologues were desig-
nated prtA1 (SCBI_0187), prtA2 (SCBI_1952), prtA3 (SCBI_
2172), and prtA4 (SCBI_3084), named for the order in which they
appear in the sequenced genome. COG analysis of all four prtA
homologues classifies these proteases as RTX toxins due to multi-
ple calcium-binding repeats and peptidase M10 serralysin C ter-
mini. prtA1 is a 1,515-bp gene that shares high identity with prtA
in S.marcescensDb11. prtA2 is a 1,419-bp gene homologous to the
prtA gene found in Photorhabdus species. prtA3 is a 1,617-bp gene
homologous to the plant-degrading proteases found in Dickeya
and Erwinia species. prtA4 is a 1,383-bp gene homologous to pro-
teases found in other Serratia species and in Dickeya species.
Temperature is an important influence on protease activity in
Serratia sp. SCBI (4). To assess the optimal temperature at which
these eight protease genes were expressed, qRT-PCR was done
utilizing RNA extracted from wild-type Serratia sp. SCBI cells
grown to stationary phase (18 h of incubation) at 22, 28, or 37°C.
Previous growth curve analysis of Serratia sp. SCBI showed that
optimal growth is seen at 28°C and 37°C, yet the rate of growth at
22°C is not significantly lower (4). Optical density readings were
determined prior to RNA extraction to ensure that the population
density of each culture was the same in order to achieve an accu-
rate comparison of gene expression. For all four prtA homologues,
the highestmRNA levels were at 28°C and the lowestmRNA levels
were at 22°C (Fig. 6A and B). The prtA2 gene showed the most
significant reduction in mRNA levels at 37°C compared to 28°C.
mRNA levels of the two serine proteases, yfgC, and the secreted
metalloprotease were highest at 22°C, but the metalloprotease
showed only slightly reduced mRNA levels at 28°C (Fig. 6C and
D). The mRNA levels of all four of these genes were significantly
reduced at 37°C.
PrtA homologues were upregulated following insect death,
while the serine proteases and other metalloproteases showed
higher mRNA levels during active infection of M. sexta. To as-
sess the importance of protease activity during insect pathogene-
sis, qRT-PCR was performed utilizing RNA extracted from expo-
nential-growth-phase cultures, from cells during hemolysis of
SRBCs, and from cells collected from either live or dead M. sexta
larvae following intrahemocoelic injection. All experiments from
which RNA was obtained were performed at the optimal temper-
ature for virulence (37°C). The prtA homologues were all signifi-
FIG 5 Analysis of the common up- and downregulated genes found among
the three SCBI mutants.
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cantly upregulated in Serratia sp. SCBI-killedM. sexta larvae com-
pared to exponential-phase cultures (Fig. 7A and B). prtA1 and
prtA2 mRNA levels increased over 200-fold compared to mRNA
levels found in exponential-phase culture. Exposure of the cul-
tures to SRBCs did not significantly increase prtA1 and prtA2
mRNA levels (Fig. 7A). A 7-fold and 10-fold increase in prtA3 and
prtA4 mRNA levels, respectively, was observed for Serratia sp.
SCBI obtained from dead M. sexta larvae compared to cells ob-
tained from exponential-growth cultures (Fig. 7B). Among the
prtA homologues, only the prtA4mRNA level showed an increase
during SRBC hemolysis. In contrast to the prtA homologues, the
serine proteases, yfgC, and the secreted metalloprotease genes
showed the highest mRNA levels in cells from active M. sexta
infections (Fig. 7C and D). Serine protease 2, yfgC, and the metal-
loprotease genes also showed an increase in mRNA levels during
hemolysis of SRBCs compared to growth in LB medium.
Expression of protease genes was downregulated in all six
transposon mutants. The mRNA levels for the known protease
genes were determined for theminiHimar RB1mutants by the use
of qRT-PCR. RNA was extracted from cultures grown to station-
ary phase at the optimal temperature for expression (28°C or
22°C). With mutants 22-A7, 22-B9, 22-C7, 22-D7, and 22-F6,
prtA1 and prtA2 mRNA levels were significantly downregulated,
showing up to a 95% decrease (Fig. 8A), while prtA3 and prtA4
mRNA levels were moderately downregulated (Fig. 8B). The ser-
ine proteasemRNA levelswere also significantly downregulated in
these mutants to the point where very little mRNA was measured
(Fig. 8C). For these mutants, the levels of yfgC and the secreted
metalloprotease mRNA showed 60 to 80% reduction from the
parental wild-type level (Fig. 8D). mRNA levels of yfgC and the
secreted metalloprotease were largely not affected in mutant 16-
D2; however, there was a reduction in mRNA of between 60 and
80% in mutants 22-A7, 22-B9, 22-C7, 22-D7, and 22-F6.
DISCUSSION
Proteases are known virulence factors in bacterial pathogens, such
as Serratia marcescens (18), Photorhabdus luminescens (38), and
Shigella flexneri (39). Protease activity plays an important role in
suppression of the host innate immune response and degradation
of host tissue. Results from our study suggest that proteases se-
creted by Serratia sp. SCBI, in particular the PrtA proteases, play a
role similar to that of the proteases found in S. marcescens, P.
luminescens, and S. flexneri. The identification of six Serratia sp.
SCBI miniHimar RB1 mutants with altered proteolytic activity
provided insight into how protease genes within this organism are
regulated and how they are secreted. All six proteasemutants were
FIG 6 Temperature influences the expression of protease genes in Serratia sp. SCBI. qRT-PCRwas performed on RNA extracted from Serratia sp. SCBI cultures
grown in LB medium for 18 h at the test temperature (22, 28, or 37°C). mRNA levels were normalized to the rplU housekeeping gene and compared to the
calibrator (SCBI at 22°C). Data are presented as the relative changes in gene expression between the values obtained with the test conditions and the calibrator.
(A to D) Levels of expression of prtA1 and prtA2 (A), prtA3 and prtA4 (B), serine protease 1 and serine protease 2 (C), and yfgC and the secreted metalloprotease
(D). Values are means  standard deviations (error bars) from at least two independent experiments. Relative gene expression values that are significantly
different (P 0.05) from the value for the calibrator (SCBI at 22°C) are indicated by an asterisk.
FIG 7 Expression of protease genes in wild-type Serratia sp. SCBI under different environmental conditions. qRT-PCR was performed on RNA extracted from
Serratia sp. SCBI during exponential-phase growth (Exp.) in LBmedium, during hemolysis of SRBCs, during active infection ofM. sexta, and following death of
M. sexta. mRNA levels were normalized to the mRNA level of rplU housekeeping gene and compared to the calibrator (exponential-phase cells). Data are
presented as the relative changes in gene expression between the values obtained with the test conditions and the calibrator. (A to D) Expression levels of prtA1
and prtA2 (A), prtA3 and prtA4 (B), serine protease 1 and serine protease 2 (C), and yfgC and the secreted metalloprotease (D). Values are means standard
deviations (error bars) from at least two independent experiments. Relative gene expression values that are significantly different (P 0.05) from the value for
the calibrator (exponential-phase cells) are indicated by an asterisk.
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no longer toxic toward the BGMK cell line, providing clear evi-
dence that protease activity is essential for cytotoxicity. However,
insect viability assays using M. sexta as a model organism gave
different results, eliminating any possibility of linking proteolytic
activity levels directly to insect pathogenesis. Nevertheless, iden-
tifying the genes inactivated in mutants 16-D2, 22-A7, 22-B9, 22-
C7, 22-D7, and 22-F6 uncovered several regulatory mechanisms
that, in addition to regulating proteolytic activity, appear to play
important roles in motility and virulence.
The location of the transposon insertion in mutant 16-D2 was
mapped to a predicted alkaline protease secretion protein, aprE.
aprE falls in the middle of a three-gene operon that is predicted to
transcribe an ABC transport system that is highly homologous to
the lipBCD system of S. marcescens (16). The inactivation of aprE
likely resulted in loss of expression of the third gene in the operon,
the outer membrane protein tolC. With two out of the three genes
no longer being transcribed, this ABC transport system would no
longer be able to secrete proteases, providing a clear-cut explana-
tion as to why there was a complete loss of detectable protease
activity inmutant 16-D2.However, upon further analysis,mutant
16-D2 also demonstrated unexpected changes in motility and vir-
ulence. Mutant 16-D2 also demonstrated a hypervirulent pheno-
type, killing M. sexta larvae in half the time it takes for wild-type
Serratia sp. SCBI to kill M. sexta.
To investigate the possible mechanisms behind the hyperviru-
lent phenotype of mutant 16-D2, RNA-seq was utilized to com-
pare levels of gene expression between this mutant and wild-type
Serratia sp. SCBI during stationary-phase growth. Genes involved
in adhesion, proteolytic activity, and direct competition with
other microbes may contribute to the hypervirulent phenotype of
mutant 16-D2. Genes involved in fimbria and P-pilus production
were upregulated, which are known virulence factors for a num-
ber of pathogens. The gene encoding the PhoPQ-activated protein
PqaA was expressed at nearly 10-fold-higher levels in the mutant
16-D2 relative to wild-type Serratia sp. SCBI. PhoPQ-regulated
genes are responsible for Salmonella virulence against mice, and
mutation of pqaA in Salmonella enterica serovar Typhimurium
affects virulence and sensitivity to the antimicrobial peptidemelit-
tin (40). Proteins involved in a type VI secretion pathway were
upregulated at least 5-fold in mutant 16-D2. In S. marcescens
Db10, a type VI secretion system (T6SS) that is nonessential for
virulence but efficiently kills other bacterial cells exists. Its activity
is required for survival when cultured with Enterobacter cloacae
(41, 42). Other genes upregulated inmutant 16-D2, whichmay be
playing a vital role in warding off competitors and thereby indi-
rectly contribute to virulence, were an ABC-type bacteriocin/an-
tibiotic exporter and the microcin H47. Overall, transcriptomic
analysis uncovered possible genetic mechanisms to explain the
hypervirulence of mutant 16-D2. However, it does not explain
how loss of a protease exporter gene results in such drastic global
effects. One hypothesis is that a buildup of proteases within the
cell may be exerting inadvertent effects on intracellular proteins,
including regulatory proteins, which may influence expression of
virulence factors.
The location of the transposon insertion in mutant 22-A7 was
mapped to a predicted BglB (also known as BglG) family antiter-
minator. In E. coli, BglG regulates the expression of the -gluco-
side utilization (bgl) operon bglGFBH (43). The Bgl system in E.
coli plays a vital role in the phosphotransferase system. There are
four Bgl family proteins in Serratia sp. SCBI, but none reside in the
beginning of an operon containing other genes involved in -glu-
coside utilization, as is found in E. coli. The BglB family antiter-
minator inactivated in mutant 22-A7 appears to be the second
gene in a two-gene operon, the first gene also being a BglB protein.
How a BglB family antiterminator could influence proteolytic ac-
tivity is unknown, as there is no precedence in the literature link-
ing this type of antiterminator to protease expression. It is possible
that this BglB is regulating protease mRNA transcripts; however,
further work, including obtaining successful complementation of
this gene inmutant 22-A7, is necessary to uncover themechanism
connecting BglB to proteolytic activity.
The location of the transposon insertion in mutant 22-B9 was
mapped to a predicted inosine/xanthosine triphosphatase.During
oxidative stress, chemical mutagenesis and oxidative deamination
result in damage to chromosomal DNA and the free nucleotide
pool (44–46). ITP andXTP are produced from the deamination of
adenine and guanine, respectively, and their incorporation into
DNA produces mutations. In order to control the concentration
of these damaging nucleotides, inosine and xanthosine triphos-
phatases target ITP and XTP for degradation. With the loss of an
inosine/xanthosine triphosphatase, as is seen inmutant 22-B9, the
mutation rate would likely increase. Therefore, a high number of
mutations may have affected genes or regulation of genes respon-
sible for the reduction in protease activity, cytotoxicity, virulence,
and hemolytic activity in mutant 22-B9.
The location of the transposon insertion in mutant 22-C7 was
FIG8 Expression of protease genes inwild-type Serratia sp. SCBI andmutants. qRT-PCRwas performed onRNA extracted fromwild-type Serratia sp. SCBI and
mutant cultures grown in LB medium for 18 h at 22°C or 28°C. mRNA levels were normalized to the rplU housekeeping gene and compared to the calibrator
(wild-type [WT] SCBI). Data are presented as the relative changes in gene expression between the values obtained from the protease mutants and the calibrator.
(A to D) Expression levels of prtA1 and prtA2 at 28°C (A), prtA3 and prtA4 at 28°C (B), serine protease 1 and serine protease 2 at 22°C (C), and the secreted
metalloprotease (exponential-phase cells) and yfgC at 22°C (D). Values aremeans standard deviations (error bars) from at least two independent experiments.
Relative gene expression values that are significantly different (P 0.05) from the value for the calibrator (WT SCBI) are indicated by an asterisk.
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mapped to a predicted tRNA uridine 5-carboxymethyl-amino-
methyl modification enzyme, GidA. The function of GidA has
been investigated in several Gram-negative bacteria. GidA is re-
quired for the addition of carboxymethylaminomethyl groups to
theC-5 carbon of uridine at position 34 of tRNAs that read codons
ending with A or G in mixed-codon families, thereby preventing
misincorporation and frameshift mutations (47, 48). The inacti-
vation of GidA in Pseudomonas, Streptococcus, Aeromonas, and
Salmonella has global effects due to loss of translational fidelity,
negatively influencing such phenotypes as virulence, antibiotic
production, hemolytic activity, proteolytic activity, cytotoxicity,
and swarming motility (49–52).
Mutant 22-C7 displayed attenuation of proteolytic activity, cy-
totoxicity, hemolysis, motility, and virulence, suggesting that
GidA plays a role in Serratia sp. SCBI similar to that in other
Gram-negative pathogens. At 1,890 bp, gidA is the same size as
gidA inAeromonas hydrophila. Microarray analysis of anA. hydro-
phila gidAmutant showed significant changes in the expression of
278 genes, and phenotypic analyses of this mutant uncovered de-
ficiencies in the invasion of intestinal epithelial cells, changes in
bacterial motility, reduced intracellular survival in macrophages,
and a reduction in cytotoxicity (51). Upregulated genes in the A.
hydrophila gidA mutant included transcriptional regulators, heat
shock proteins, and proteins involved in iron transport, whereas
downregulated genes included genes important in invasion, fla-
gellar genes, type 3 secretion system pathway genes, and motility
and chemotaxis genes. Inactivation of gidA in Serratia sp. SCBI
also appears to have an effect on gene expression levels. qRT-PCR
results showed that prtA1, prtA2, serine proteases 1 and 2, yfgC,
and the secreted metalloprotease were all significantly downregu-
lated. RNA-seq analysis showed 258 genes with altered expression
in mutant 22-C7. The types of genes showing alterations in gene
expression were similar to those in S. enterica. A high number of
genes involved in transcriptional and translational regulation
were upregulated in mutant 22-C7. In terms of downregulated
genes, several genes involved in flagellar production had signifi-
cantly decreased expression as well as the surface adhesion, spaP,
which is involved in type 3 secretion systems, similar to the S.
enterica gidA mutant. In contrast to the S. enterica gidA mutant,
Serratia sp. SCBI mutant 22-C7 had a decrease in iron transport
genes. Also of note in mutant 22-C7 was a decrease in expression
of a phospholipase D gene and three genes involved in fimbrial
production, all of which likely contributed to the decrease in vir-
ulence of this mutant.
The location of the transposon insertion in mutant 22-D7 was
mapped tomethyl-accepting chemotaxis protein (MCP) II.MCPs
are transmembrane sensor proteins in bacteria that function in the
detection of molecules in that environment. Recently, it has been
shown that in addition to motility, MCPs also play a role in regu-
lating virulence in such pathogens as Pseudomonas aeruginosa (53,
54). The MCP inactivated in mutant 22-D7 falls into the category
of an orphanMCP, as its two-component system partners are not
immediately apparent. With a severe reduction in proteolytic ac-
tivity, cytotoxicity, and virulence, as well as significant downregu-
lation of expression in a number of protease genes, it is possible
that this MCP interacts with a pathway involved in the regulation
of either a second messenger, such as cAMP, or that its corre-
sponding response regulator is a DNA-binding protein the di-
rectly controls transcription of protease and virulence-related
genes. Further work is needed to characterize this orphan MCP
and its partners in order to understand its role in proteolytic ac-
tivity and virulence.
The location of the transposon insertion in mutant 22-F6 was
mapped to a 381-bp nucleic acid-binding protein, which contains
a PIN domain. PIN domain proteins are found in bacteria, ar-
chaea, and eukaryotes. The function of PIN domain proteins in
eukaryotes, including humans, is to eliminate mRNA transcripts
containing premature stop codons, a process otherwise known as
nonsense-mediated mRNA decay (55–57). In prokaryotes, PIN
domain proteins often function as the toxin in toxin-antitoxin
(TA) systems. The largest class of type II toxin-antitoxin systems
in prokaryotes is theVapBCTA system, inwhichVapC is the toxin
and VapB serves as the matching antitoxin. VapBC TAs in such
organisms as Sinorhizobium meliloti, Mycobacterium smegmatis,
and Neisseria gonorrhoeae appear be involved in metabolic pro-
cesses during host interactions and under stressful conditions by
targeting an array of mRNA transcripts for degradation (58–60).
The VapBC TAs in Salmonella enterica and Shigella flexneri are
induced by amino acid starvation and chloramphenicol, resulting
in a bacteriostatic condition (61). The PIN domain protein inac-
tivated in mutant 22-F6 shows high sequence similarity with
VapC toxins from Sinorhizobiummeliloti, Salmonella enterica, and
Shigella flexneri. Although further work is needed to confirm that
this PIN domain protein and the upstream CopG DNA-binding
protein constitute a bona fide TA locus, they do appear to be
transcribed polycistronically and are the same size as other VapBC
TAs, at 126 and 73 amino acids, respectively. Phenotypic and
qRT-PCR results suggest that one function of this PIN domain
protein in Serratia sp. SCBI is to regulate proteolytic activity. In
addition, RNA-seq analysis of mutant 22-F6 showed significant
changes in the expression of a high number of genes involved in
transcriptional or translational regulation, including increased
expression of the PINdomain protein hit by the transposon in this
mutant and its operon partner, CopG. Given the nature of regu-
lation of VapBC TAs, the mutation of the PIN domain protein
likely results in a decreased ability to bind to CopG and prevent
transcription of these two genes. Therefore, without negative au-
toregulation, there is increased expression of both genes. Further
genetic analysis of both the PIN domain protein andCopG should
shed light on the function of this predicted TA system.
Though the results of the transposon mutant screen were suc-
cessful in uncovering mechanisms important in protease activity,
there was a distinct lack of data on the individual protease genes in
Serratia sp. SCBI. Therefore, the genome of Serratia sp. SCBI was
analyzed to identify predicted protease genes and to perform ex-
pression studies of these genes to gain further understanding of
their possible role in various environmental conditions, including
pathogenesis. The high number of prtA homologues foundwithin
Serratia sp. SCBI indicated that these types of proteases are impor-
tant to this organism. There is high sequence similarity between
prtA1 and prtA2 to the prtA genes found in S. marcescens and P.
luminescens, respectively, giving an indication of the function of
each protease. In S. marcescens, PrtA is linked to destruction of
mammalian immune system components (15, 25) and cytotoxic-
ity (27). Similarly, PrtA from P. luminescens is important in cyto-
toxicity and shows its highest expression following death of the
insect host (62, 63). Given the high mRNA levels seen for prtA1
and prtA2 following the death of Serratia sp. SCBI-killedM. sexta
larvae and loss of cytotoxicity in all six attenuated mutants, these
two proteases could be largely responsible for destruction of host
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tissue and acquisition of cell-bound nutrients. The results of the
azocasein assay, which showed that themajority of protease activ-
ity by Serratia sp. SCBI is metalloprotease based, further supports
the possibility that prtA1 and prtA2 are the genes encoding the two
most important enzymes involved in proteolytic activity. In addi-
tion, prtA3 and prtA4 also showed elevatedmRNA levels following
the death of Serratia sp. SCBI-killed M. sexta larva, they but did
not show as great of an increase as the prtA1 and prtA2 genes did.
The expression data for the remaining protease genes analyzed in
this study, two serine proteases and two metalloproteases, indi-
cates that these enzymes may be more important in active infec-
tion. Without deletion of these genes individually, it is impossible
to determine their true function, and unfortunately, screening of
the Serratia sp. SCBI miniHimar RB1 transposon library failed to
provide any hits in a protease gene. Increasing the number of
mutants in the library could have provided a mutant with an in-
activated protease gene, as only 2,100mutants were tested, and the
genome of Serratia sp. SCBI contains approximately 4,849 genes.
However, there is a high redundancy of protease genes in the Ser-
ratia sp. SCBI genome, and inactivation of one protease gene is
unlikely to affect the phenotype to any significant extent. Attempts
at site-directed mutagenesis of prtA1 and prtA2 by lambda Red
recombination were unsuccessful. Further analysis of these genes,
and a successful site-directed mutagenesis system for Serratia sp.
SCBI, is needed to understand the individual function of prtA1,
prtA2, and the other protease genes.
Overall, this study has uncovered the importance of protease
activity in the cytotoxic effects seen on mammalian cells by Serra-
tia sp. SCBI. This study has also laid the foundation for further
work on characterizing the molecular pathways governing pro-
tease activity in Serratia sp. SCBI. The redundancy of protease
geneswithin the Serratia sp. SCBI genomeunderscores the impor-
tance of proteolytic activity in the lifestyle of this insect pathogen.
It is likely that Serratia sp. SCBI secretes proteases throughout the
infective process in the insect host, yet the data collected more
strongly supports the role of proteases in the breakdown of the
insect cadaver and bioconversion of host tissue. Results from the
transposon library provided evidence that Serratia sp. SCBI pro-
teolytic activity drives the destruction of mammalian cells. The
major secretion pathway for extracellular proteases appears to be
through an ABC transport system, though other secretory path-
ways may exist. Regulation of Serratia sp. SCBI protease genes
appears to be controlled by several differentmechanisms that have
no precedence in the literature. A methyl-accepting chemotaxis
protein, BglB family antiterminator, a PIN domain protein, and
the global regulator GidA are all putatively involved in the regu-
lation of proteases at either the transcriptional or translational
level. RNA-seq analysis highlighted a number of genes that are
likely contributing to the hypervirulence of mutant 16-D2 and
include the PhoPQ operon, adhesion genes, type VI secretion
genes, and PrtA4. Transcriptome analysis showed that the regula-
tory role of GidA in Serratia sp. SCBI appears to be similar to its
role in other Gram-negative pathogens. The PIN domain protein
inactivated in mutant 22-F6 is likely part of a toxin-antitoxin sys-
tem, and its loss resulted in significant changes in transcription
and translation, which is not surprising given the nature of toxin-
antitoxin systems in bacteria. Further investigations into the six
genes inactivated by transposon insertion should shed light on the
specific mechanisms that not only control protease activity but
other important physiological characteristics as well.
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